阿魏酸钠、刺五加注射液对慢性肺源性心脏病急性期临床疗效对比研究

目的 探讨阿魏酸钠、刺五加注射液治疗慢性肺心病急性发作的临床疗效.方法 对90例慢性肺心病急性发作期患者进行了随机对照研究,对照组常规给予持续低流量吸氧、抗生素控制感染、止咳、社痰、平喘等对症治疗;治疗1组在常规治疗的基础上加用阿魏酸钠0.2 g静滴,1次/d,连用14 d;治疗2组在常规治疗的基础上加用刺五加注射液100 ml静滴,1次/d,连用14 d.观察治疗前后血气分析(动脉血氧分压、动脉血二氧化碳分压、动脉血氧饱和度)、血液流变学(全血高切黏度、全血低切黏度、全血还原黏度、红细胞聚集指数、血细胞比容)的变化及临床疗效.结果 与对照组相比.两治疗组的血气分析结果改善明显,两治疗组间未见明显差异(P＞0.05).两治疗组血液流变学均较治疗前有明显改变(P均＜0.05),两治疗组间无显著差异(P＞0.05),与对照组比较均有显著差异(P均＜0.05).临床疗效两治疗组与对照组比较有显著差异(P均＜0.05),两治疗组间无显著差异(P＞0.05).结论 阿魏酸钠、刺五加注射液对慢性肺心病急性期有明显的干预治疗作用;二者临床疗效明显优于对照组,而二者之间未见明显差异.

Comparative Study on Treatment of Chronic Pulmonary Heart Disease at Acute Stage with Sodium Ferulate and with Ciwujia Injection separately

Objective To investigate the clinical effects of treatment of chronic pulmonary heart disease (CPHD) at acute stage with sodium ferulate and Ciwujia injection. Methods 90 cases of CPHD at acute stage were recruited into treatment group 1, treatment group 2 and control group. The control group was treated with consistent inhalation of oxygen,antibiotics, and symptomatic therapies like relieving cough, removing sputum, and stopping wheeze. The treatment group 1was treated with sodium ferulate, Ⅳ 0.2g, once daily for successive 14days, in addition to the conventional treatment. The treatment group 2 was treated with Ciwujia Injection, 100ml Ⅳ, once daily for successive 14 days. Observe the curative effect and the changes of blood gas analysis indexes (PAo2, PaCO2, SAO2) and bemorheological indexes (whole blood high-cutting viscosity, whole blood low-cutting viscosity, whole blood recovery viscosity, erythrocyte aggregation index, and HCT) before and after treatment. Result Compared with the control group, both treatment groups got improvement in blood gas analysis indexes and hemorheological indexes and curative effect, but no significant difference between the two groups (P＞0.05).Conclusion both sodium ferulate and Ciwujia injection had good results in treating CPHD at acute stage, and there was no difference between the two medicines in terms of curative effects.